Home Health Care News November 14, 2022
Joyce Famakinwa

Coming down from a high the past two years, home-based care M&A saw a bit of slowdown in the third quarter of 2022. That’s according to a recent report from Mertz Taggart.

The report is an overview of the dealmaking activity that took place across home health, home care and hospice in Q3.

The decline in transactions is a result of fewer companies going to market in 2022, compared with 2020 to 2021, Mertz Taggart Managing Partner Cory Mertz said in the report.

“Transaction volume from late 2020 through 2021, relative to historical periods, was up almost 40%,” he said. “This was driven by sellers trying to get their transactions closed before the then-pending capital gains tax rate increase. This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Post-Acute Care, Provider, Survey / Study, Trends
In the Pipeline: LifeSpire of Virginia Announces $80M Renovation Plan; Oak Trace Completes Multiphase $112M Campus Redevelopment
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Digital health venture capital deals stagnate
Ascension continues selling spree
Acadia Executes 3 New Acquisitions, Fueling 2024 Growth Strategy

Share This Article